SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-23-039483
Filing Date
2023-02-15
Accepted
2023-02-14 19:09:05
Documents
2
Group Members
FREDERICK V. FORTMILLER, JR.HARRADEN CIRCLE INVESTORS GP, LLCHARRADEN CIRCLE INVESTORS GP, LPHARRADEN CIRCLE INVESTORS, LP

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d453286dsc13ga.htm SC 13G/A 97355
2 EX-99.1 d453286dex991.htm EX-99.1 6962
  Complete submission text file 0001193125-23-039483.txt   106124
Mailing Address 105 BRADFORD ROAD, SUITE 420 WEXFORD PA 15090
Business Address 105 BRADFORD ROAD, SUITE 420 WEXFORD PA 15090 724-934-6467
Coeptis Therapeutics Holdings, Inc. (Subject) CIK: 0001759186 (see all company filings)

IRS No.: 981465952 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-91807 | Film No.: 23632786
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 299 PARK AVE 21ST FLOOR NEW YORK NY 10171
Business Address 299 PARK AVE 21ST FLOOR NEW YORK NY 10171 212 832 4111
Harraden Circle Investments, LLC (Filed by) CIK: 0001910592 (see all company filings)

IRS No.: 813057945 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A